<?xml version="1.0" encoding="UTF-8"?>
<ref id="B133-pharmaceuticals-13-00096">
 <label>133.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yu</surname>
    <given-names>C.M.</given-names>
   </name>
   <name>
    <surname>Wong</surname>
    <given-names>R.S.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>E.B.</given-names>
   </name>
   <name>
    <surname>Kong</surname>
    <given-names>S.L.</given-names>
   </name>
   <name>
    <surname>Wong</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Yip</surname>
    <given-names>G.W.</given-names>
   </name>
   <name>
    <surname>Soo</surname>
    <given-names>Y.O.</given-names>
   </name>
   <name>
    <surname>Chiu</surname>
    <given-names>M.L.</given-names>
   </name>
   <name>
    <surname>Chan</surname>
    <given-names>Y.S.</given-names>
   </name>
   <name>
    <surname>Hui</surname>
    <given-names>D.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Cardiovascular complications of severe acute respiratory syndrome</article-title>
  <source>Postgr. Med. J.</source>
  <year>2006</year>
  <volume>82</volume>
  <fpage>140</fpage>
  <lpage>144</lpage>
  <pub-id pub-id-type="doi">10.1136/pgmj.2005.037515</pub-id>
 </element-citation>
</ref>
